RGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer growth by blocking p21Ras-GTP

Peng Lin(Kunming University of Science and Technology), Ju-Lun Yang(Kunming University of Science and Technology)

BMC Cancer

January 12, 2024

10.1186/s12885-023-11686-5

Cited by 1

Related Papers

Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells

|BMC Cancer|2018|21

RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480

|BMC Cancer|2021|15

BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor

|PLoS ONE|2022|9